Utility of D-Dimer for mortality prediction in patients at risk for pulmonary hypertension
V. Foris (Graz, Austria), F. Prüller (Graz, Austria), G. Kovacs (Graz, Austria), A. Avian (Graz, Austria), P. Douschan (Graz, Austria), M. Herrmann (Graz, Austria), H. Olschewski (Graz, Austria)
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Foris (Graz, Austria), F. Prüller (Graz, Austria), G. Kovacs (Graz, Austria), A. Avian (Graz, Austria), P. Douschan (Graz, Austria), M. Herrmann (Graz, Austria), H. Olschewski (Graz, Austria). Utility of D-Dimer for mortality prediction in patients at risk for pulmonary hypertension. 1527
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
emPHasis-10 score predicts mortality in patients with pulmonary hypertension Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018
MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020
Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020
Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model Source: Eur Respir J, 52 (4) 1800497; 10.1183/13993003.00497-2018 Year: 2018
Usefulness of FVC/DLCO ratio to stratify the risk of mortality in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016
Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin Source: Eur Respir J 2015; 46: 1701-1710 Year: 2015
Arterial hypertension and the risk of severity and mortality of COVID-19 Source: Eur Respir J, 55 (6) 2001148; 10.1183/13993003.01148-2020 Year: 2020
Validation of a prognostic score for pulmonary embolism short-term mortality Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015
Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010
Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020
Non-invasive mortality predictors in pediatric pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010
Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy Source: Eur Respir J, 51 (4) 1702576; 10.1183/13993003.02576-2017 Year: 2018
External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension Source: ERJ Open Res, 8 (1) 00006-2022; 10.1183/23120541.00006-2022 Year: 2022
The signifigance of NT-proBNP value pulmonary tromboembolism in early mortality Source: Annual Congress 2006 - Pulmonary embolism Year: 2006
Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF) Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018
Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015
Management of acute pulmonary thrombo-embolic disease (PTE) linking mortality risk to treatment strategies Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009
Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1702310; 10.1183/13993003.02310-2017 Year: 2018
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model Source: Eur Respir J, 50 (2) 1700740; 10.1183/13993003.00740-2017 Year: 2017
Prevalence of pulmonary hypertension among COPD patients: screening by echocardiography and NT-PROBNP Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009